کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2804363 | 1156868 | 2013 | 5 صفحه PDF | دانلود رایگان |

ObjectiveEmerging evidence indicates that metabolic syndrome (MetS) predisposes diabetic subjects to nephropathy. Aside from hypertension and hyperglycemia, it is unclear which component of MetS also contributes to increased urinary albumin excretion (UAE). We compared the MetS profiles of subjects divided into two groups based on their UAE.MethodsThe Asia Pacific Real-Life Effectiveness and Care Patterns of Diabetes Management (AP RECAP-DM) study is a cross-sectional survey in which type 2 diabetic subjects using oral anti-hyperglycemic drugs were enrolled. We analyzed the data of 162 type 2 diabetic subjects with normotension or taking antihypertensive medications.ResultsThere were 123 subjects with normal UAE (< 30 mg/g) and 39 with abnormal UAE (≥ 30 mg/g). MetS was more prevalent in the abnormal UAE group (79.5%) than in the normal UAE group (58.5%) (P = 0.018). Hypertriglyceridemia (odds ratio = 8.65, P < 0.001) and reduced high-density lipoprotein (HDL) cholesterol (odds ratio = 3.27, P = 0.022) were both independently associated with abnormal UAE. Using 3.4 as a cut-off value, a high triglyceride-to-HDL cholesterol ratio was a useful marker (odds ratio = 15.05, P < 0.001) for abnormal UAE.ConclusionsA high triglyceride-to-HDL cholesterol ratio was found to be an important risk factor for nephropathy in type 2 diabetic subjects.
Journal: Journal of Diabetes and its Complications - Volume 27, Issue 3, May–June 2013, Pages 243–247